AdaptHealth Maintains FY22 Guidance

Guidance Maintained for Fiscal Year 2022 The Company is maintaining its previously issued financial guidance for fiscal year 2022, as follows: Net revenue of $2.840 billion to $3.040

Guidance Maintained for Fiscal Year 2022

The Company is maintaining its previously issued financial guidance for fiscal year 2022, as follows:

  • Net revenue of $2.840 billion to $3.040 billion;
  • Adjusted EBITDA of $615 million to $675 million; and
  • Total capital expenditures representing 9-11% of net revenue.

Guidance for fiscal year 2022 does not include any contribution from acquisitions that have not yet closed, or continuing Public Health Emergency benefits beyond the currently scheduled expiration date.

Total
0
Shares
Related Posts